Home-based AIDS care program could benefit HIV-infected people in rural Africa

November 01, 2006

A novel home-based AIDS care programme can achieve good adherence and response to antiretroviral therapy in a rural African setting, according to an Article in this week's issue of The Lancet.

Access to antiretroviral therapy is expanding in resource-limited settings but transport costs prevent many of those in need from getting to health facilities to receive treatment. Paul Weidle and colleagues from the Centers for Disease Control and Prevention in the USA assessed the effectiveness of a home-based approach to AIDS care in rural Uganda. The programme uses trained lay people who regularly visit participants at home to deliver medication and to collect information about adherence to antiretroviral therapy and possible toxic effects.

Over 980 adults who had received no previous antiretroviral therapy were enrolled into the study between July 2003 and May 2004. The researchers found that the majority of patients had good adherence to antiretroviral therapy and that this was associated with sustained suppression of HIV during the first year of treatment.

Dr Weidle concludes: "In Uganda, where the majority of HIV-infected people reside in rural areas and families live on less than US$1/day per person, transportation costs can pose an important barrier to adherence success. Home delivery of antiretroviral therapy could reduce this barrier, although direct weekly delivery to clients' homes might not be achievable in all settings. Home delivery might be more feasible on a monthly or quarterly basis, which would reduce costs substantially and allow a single field officer to cover between 100 and 300 participants."
-end-
EMBARGO: 00:01H (London time) Friday November 3, 2006. In North America the embargo lifts at 18:30H ET Thursday November 2, 2006.

Contact: Office of Communications, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. T) 404-639-8895

Lancet

Related Antiretroviral Therapy Articles from Brightsurf:

Antiretroviral therapy can't completely stop accelerated cell aging seen in HIV
Untreated HIV infection is linked with epigenetic changes that suggest rapid aging.

Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital
Antiretroviral therapy (ART) failure and drug resistance are extremely common in patients living with HIV who are admitted to hospital in Malawi, according to new research published in Lancet HIV.

Sugar-based signature identifies T cells where HIV hides despite antiretroviral therapy
Wistar scientists may have discovered a new way of identifying and targeting hidden HIV viral reservoirs during treatment with antiretroviral therapy (ART).

HIV reservoirs in humans: Immediate antiretroviral therapy makes them 100 times smaller
Thanks to an unprecedented access to blood, and biopsies of rectums and lymph nodes of people at the earliest stages of HIV infection, an international team of researchers at the University of Montreal Hospital Research Centre (CRCHUM), the US Military HIV Research Program and the Thai Red Cross AIDS Research Centre has shown that the first established reservoirs are still 'sensitive' during these early stages and could be downsized about 100 times upon immediate ART initiation.

Changes in the cost over tine of HIV antiretroviral therapy in US
Researchers calculated the average cost of recommended initial HIV antiretroviral therapy (ART) regimens in the US from 2012 to 2018 and analyzed how this cost has changed over the years.

Study suggests antiretroviral therapy does not restore disease immunity
A study led by researchers from SUNY Downstate Health Sciences University and Oregon Health & Science University, published in the Journal of Infectious Diseases, showed that, despite successful antiretroviral therapy (ART), antigen specific memory to vaccinations that occurred before HIV infection did not recover, even after immune reconstitution.

Immediate treatment with antiretroviral therapy helps infants with HIV
As part of an international collaborative effort, investigators from Brigham and Women's Hospital conducted immunological and virological testing on newborns in Botswana, finding that initiating antiretroviral therapy immediately, rather than waiting a few weeks, provided measurable benefits for infants born with HIV.

HIV may affect the brain despite ongoing antiretroviral therapy
HIV-positive patients are living longer thanks to combination antiretroviral therapy (cART), but the virus can remain in some tissues, preventing a total cure.

Being HIV positive and staying on antiretroviral therapy in Africa: A systematic review
An international team of researchers have carried out a review of the evidence examining what influences people who are HIV positive to go to health services and then stay on antiretroviral drugs in Africa.

Benefits of early antiretroviral therapy in HIV-infected children
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker -- AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.

Read More: Antiretroviral Therapy News and Antiretroviral Therapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.